OFF DUTY COOK BOOK - For the perfect present and a great way to support nsif. Please see



We are delighted to have the support and sponsorship of local company, Portable Building Sales Limited, and are pleased to recommend their services. 

Having been a loyal supporter of the charity for a number of years, their further very generous donation of £2,000 for the Bridge to Bridge 3 cycle challenge has enabled us recently to surpass the milestone of £100,000 raised by nsif Hull & ER since inception. Please see:-

Professor Geoffrey Raisman

Professor Geoffrey Raisman FRS is a world-class British neuroscientist who leads a dedicated team, pioneering the repair of spinal cord injuries. He is a pioneer in the field of spinal injuries and has received funding from nsif.


He is Chair of Neural Regeneration at University College London’s Institute of Neurology at Queen Square, and is a Fellow of the Royal Society and the Academy of Medical Sciences.

Professor Raisman’s ground-breaking work at the University of Oxford established for the first time that the adult brain and spinal cord respond to injuries by forming new connections.

In 1980, Professor Raisman received the Wakeman Award for Research in the Neurosciences. In 1985, he discovered a type of cell, the olfactory ensheathing cell (OEC), which guides the natural regeneration of the nerve fibres that carry the sense of smell from the nose to the brain.

In 2005, Professor Raisman was awarded the Reeve-Irvine medal for critical contributions to promoting repair of the damaged spinal cord and recovery of function. Together with Dr Ying Li and Dr Daqing Li, the team has shown that transplantation of these cells into spinal cord injuries in laboratory models results in regeneration of severed nerve fibres and restoration of function. The team is now working on the practical steps needed to apply this approach to spinal injured patients.

Professor Raisman believes success in patients with spinal cord injuries will in future open the way to applying similar principles to devise new approaches to stroke, blindness and deafness.